---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-006292"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2025-05-05T23:59:59+00:00"
generated_at: "2026-05-22T16:12:47.149097+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q1 revenue flat, net loss widens; lowers FY 2025 revenue and EBITDA guidance

## Summary
- Q1 2025 revenue $61.3M (+0.3% YoY); net loss $3.0M vs $2.2M loss in Q1 2024.
- Adjusted EBITDA loss $0.3M vs positive $1.0M in prior-year quarter.
- Lymphedema product sales -3% YoY; airway clearance +22% YoY.
- FY 2025 revenue guidance lowered to $309-315M (prior $316-322M); EBITDA guidance cut to $32-34M from $35-37M.
- Repurchased $10M of stock in Q1; $16.5M remaining under $30M buyback program.

## SEC filing metadata
- accession: 0001558370-25-006292
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2025-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000155837025006292/0001558370-25-006292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000155837025006292/tcmd-20250505x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-006292
- JSON: https://secwatch.observer/filing/0001558370-25-006292.json
- Plain text: https://secwatch.observer/filing/0001558370-25-006292.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.